Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38178

IQCN Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The IQCN Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population that disrupts IQCN in HEK293T cells, providing a loss-of-function model for studying this calmodulin-binding IQ domain protein. IQCN is implicated in calcium-dependent cytoskeletal regulation, interacting with calmodulin and influencing actin and myosin dynamics. This product is ideal for functional characterization of IQCN, proteomic interaction screening, and calcium signaling studies. Researchers can validate knockout via Sanger sequencing and Western blotting, assess phenotypes with immunofluorescence and co-immunoprecipitation, and measure calcium flux to probe signaling alterations.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    IQCN

    Gene Identifier

    NCBI Gene ID 80726

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The IQCN Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for the functional study of the IQCN gene. This product provides a loss-of-function model generated through targeted disruption of IQCN in a heterogeneous pool of HEK293T cells, enabling researchers to investigate the gene’s role in calcium-dependent cytoskeletal regulation without clonal selection artifacts.

The HEK293T host cell line is a widely utilized derivative of the HEK293 human embryonic kidney cell line, engineered to stably express the SV40 large T antigen. This modification enhances episomal replication of plasmids containing the SV40 origin of replication, making HEK293T cells highly efficient for transient protein expression, viral production, and gene delivery applications. Their robust growth characteristics and high transfection efficiency render them a versatile platform for genetic manipulation and downstream functional assays.

IQCN encodes a calmodulin-binding IQ domain-containing protein that is proposed to function as a regulator of cytoskeletal dynamics through calcium-mediated signaling. The protein interacts directly with calmodulin in a calcium-dependent manner and is positioned within a pathway that includes upstream regulators calcium and calmodulin, as well as downstream effectors actin and myosin. Mechanistically, IQCN is thought to participate in calcium-triggered cytoskeletal reorganization, potentially influencing actin filament assembly or actomyosin contractility. Disruption of IQCN is therefore expected to perturb these calmodulin-dependent processes, offering a valuable tool to dissect its precise molecular contributions.

In the context of HEK293T cells, knockout of IQCN provides a controlled system to examine how loss of this calmodulin-binding protein affects actin dynamics and calcium signaling. HEK293T cells possess a well-characterized signaling repertoire and are amenable to a wide range of biochemical and imaging techniques, making them an ideal background for studying relatively uncharacterized genes such as IQCN. The polyclonal nature of the knockout population avoids potential clonal variation while still enabling robust detection of phenotype, particularly when combined with appropriate controls.

This knockout model is well-suited for a variety of research applications, including the functional characterization of IQCN, proteomic interaction screening to identify novel binding partners, and detailed calcium signaling studies. Researchers can validate the knockout status using Sanger sequencing, confirm loss of protein expression via Western blotting, and assess transcriptional changes by RT-qPCR. Cellular phenotyping can be performed through immunofluorescence to visualize cytoskeletal alterations, while functional assays such as calcium flux measurements and co-immunoprecipitation can probe the protein’s role in dynamic signaling networks. For further technical information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)